Key result
Pre-transplant LV GLS linked to MACE following kidney transplantation.
Why the study?
The value of left ventricular global longitudinal strain (GLS) for cardiovascular risk assessment in kidney transplant recipients has not been well studied.
Does abnormal pre-transplant left ventricular global longitudinal strain predict major adverse cardiovascular events in adult kidney transplant recipients?
Cohort (n=341)
No
Does abnormal pre-transplant left ventricular global longitudinal strain predict major adverse cardiovascular events in adult kidney transplant recipients?
Pre-transplant left ventricular global longitudinal strain is independently associated with long-term major adverse cardiovascular events in kidney transplant recipients, offering better prognostic value than left ventricular ejection fraction.
May refine cardiovascular risk stratification in kidney transplant candidates; extends GLS prognostic data to this population.
PURPOSE: Cardiovascular disease (CVD) remains the leading cause of death among kidney transplant recipients (KTRs). Current guidelines recommend using left ventricular global longitudinal strain (GLS) for the early identification of cardiac dysfunction, but its value in KTRs has not been well studied. METHODS: We performed a single-center retrospective cohort study of adult KTRs who underwent KT between January 2015 and January 2024 and had an adequate-quality pre-transplant echocardiogram. Patients without follow-up at our institution or with atrial fibrillation were excluded. GLS was measured using vendor-independent two-dimensional speckle-tracking software, with abnormal GLS defined as absolute GLS < 16% (lower absolute strain magnitude), with higher values indicating better systolic function. Patients were divided into normal GLS (NGLS) or abnormal GLS (AbGLS) groups. The primary outcome was major adverse cardiovascular events (MACE), defined as cardiovascular death, acute coronary syndrome, stroke, hospitalization for heart failure, or major arrhythmia. Kaplan-Meier survival curves and Cox proportional hazards models were constructed for statistical analysis. RESULTS: Of 518 screened KTRs, 341 met the study criteria. Compared with NGLS patients (n = 159), AbGLS patients (n = 182) were older (55.1 vs. 51.5 years) and had a significantly higher prevalence of hypertension, diabetes mellitus, and coronary artery disease. Over a mean follow-up of 52.7 ± 28.3 months, Kaplan-Meier analysis demonstrated a significantly higher cumulative incidence of MACE in the AbGLS group, with a 5-year incidence of 27.1% versus 9.4% in NGLS (log-rank p = 0.002). In multivariable Cox regression adjusted for confounding variables identified from univariate regression, GLS was independently associated with MACE (adjusted HR 0.94; 95% CI 0.88-1.00; p = 0.04), whereas left ventricular ejection fraction was not. CONCLUSION: In this retrospective single-center study, GLS was independently associated with MACE in KTRs, supporting a potential role for GLS in cardiovascular risk assessment in KT candidates.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) conducted a cohort in Kidney transplant recipients (n=341). Abnormal global longitudinal strain (GLS < 16%) vs. Normal global longitudinal strain was evaluated on Major adverse cardiovascular events (MACE), defined as cardiovascular death, acute coronary syndrome, stroke, hospitalization for heart failure, or major arrhythmia (HR 0.94, 95% CI 0.88-1.00, p=0.04). Abnormal pre-transplant global longitudinal strain was associated with a higher 5-year incidence of MACE compared to normal strain (27.1% vs 9.4%; adjusted HR 0.94; 95% CI 0.88-1.00; p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: